Among the companies with shares expected to actively trade in
Wednesday's session are Realogy Holdings Corp. (RLGY), Health
Management Associates Inc. (HMA) and Actions Semiconductor Co.
(ACTS).
Realogy Holdings Corp. projected first-quarter results below
analysts' expectations, although an improvement in sales helped
results top year-earlier comparisons. The real estate broker's
shares slid 7.3% to $41.55 after hours Tuesday.
Health Management Associates Inc. cut its full-year revenue
outlook and said it expects first-quarter earnings and revenue to
fall short of analysts' expectations as the hospital operator said
inpatient admissions sank. Shares fell 10% to $11.27 after
hours.
Actions Semiconductor raised its first-quarter revenue outlook
as the company said it has seen stronger-than-expected sales of its
newest chipset for tablets. Shares were up 8% to $2.85 after
hours.
Durata Therapeutics Inc. (DRTX) will offer about $50 million of
its shares, with plans to use proceeds to seek marketing approval
in the U.S. and the European Union for dalbavancin, its treatment
for certain skin infections. The company had a recent market
capitalization of $156 million, according to FactSet. Shares
dropped 2.7% to $8.15 in after-hours trading.
Resource Capital Corp. (RSO) said it has begun an offering of
about 16.3 million shares and intends to use proceeds for general
corporate purposes. The REIT had about 108.3 million shares
outstanding as of April 5. Shares slipped 3.2% to $6.32 after
hours.
PriceSmart Inc.'s (PSMT) fiscal second-quarter earnings rose 23%
as the company continued to post double-digit sales growth at its
warehouse clubs. The discount-club store operator's shares were up
3.6%, at $83.08 in recent after-hours trading, as earnings and
revenue topped expectations.
SeaChange International Inc. (SEAC) swung to a fiscal
fourth-quarter profit as the video-software company posted stronger
product revenue and lower operating expenses. However, shares were
down 6.1% at $10.71 after hours as the company offered
current-quarter guidance below analyst expectations.
Synergy Pharmaceuticals Inc. (SGYP) said it intends to offer
shares valued at about $90 million and wants to use the proceeds to
fund research and development activities including further clinical
development of its constipation drug plecanatide and other pipeline
programs. The biopharmaceutical firm recently had a market
capitalization of $458 million, according to FactSet. Shares were
down 10% to $6.50 after hours.
Watchlist:
Blackstone Group LP is talking to several technology companies
about potentially joining its bid to take computer maker Dell Inc.
(DELL) private, The Wall Street Journal reported citing people
familiar with the matter.
Healthcare Services Group Inc.'s (HCSG) first-quarter earnings
rose 74% as the company continued to post stronger revenue and
margins.
Infinity Pharmaceuticals Inc. (INFI) said its stockholders
Beacon Co. and Rosebay Medical Company LP will offer 8.5 million of
the drug developer's shares. Infinity, which had more than 47.8
million shares outstanding as of March 31, won't receive any
proceeds from the offering.
A Nevada jury said two UnitedHealth Group Inc. (UNH) units
should pay a total of $500 million in punitive damages in a case
involving two members who contracted hepatitis C, an award that
will draw close attention in the health-insurance industry.
-Write to Nathalie Tadena at nathalie.tadena@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires